First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Future Directions for Precision Medicine in Advanced NSCLC

Peer Exchange

Resistance Mechanisms and Sequencing for EGFR+ NSCLC

Advances in Frontline Therapy for EGFR+ NSCLC

Promising EGFR Inhibitors in Development for NSCLC

Frontline Chemo and TKI Combination in EGFR+ NSCLC

Adjuvant TKI for Early Stage EGFR+ NSCLC

Updates in the Treatment of ALK+ and ROS1+ NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Second Generation ALK Inhibitors in NSCLC

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

NTRK Gene Fusions: Rare Yet Actionable

Targeting HER2 Mutations in NSCLC: What Do We Know?

Response Rates in Treatment of MET-Amplified NSCLC

Advances in RET Inhibition in NSCLC

Mutation Testing for All Patients With NSCLC